Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Evogene (EVGN)
NASDAQ:EVGN
Holding EVGN?
Track your performance easily
EVGN Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.72 - $10.40
Previous Close$2.74
Volume7.59K
Average Volume (3M)23.32K
Market Cap
$13.40M
Enterprise Value$567.26K
Total Cash (Recent Filing)$31.06M
Total Debt (Recent Filing)$1.14M
Price to Earnings (P/E)―
Beta1.32
Next Earnings
Nov 13, 2024EPS Estimate
-$1.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.95
Shares Outstanding5,079,000
10 Day Avg. Volume11,421
30 Day Avg. Volume23,325
Standard Deviation0.26
R-Squared0.08
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)1.16
Price to Sales (P/S)2.56
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.73
Enterprise Value/Gross Profit0.14
Enterprise Value/Ebitda-0.04
Forecast
1Y Price Target
$17.25Price Target Upside551.14% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Evogene News
PremiumCompany Announcements
Evogene Announces Major Management Restructuring
PremiumCompany Announcements
Evogene Ltd. Reports Mid-Year Financial Dip
PremiumCompany Announcements
Evogene Issues Series A Share Purchase Warrants
PremiumCompany Announcements
Evogene Reports Growth and R&D ProgressOwnership Overview
0.00%
Insiders
1.17% Mutual Funds
0.00% Other Institutional Investors
98.83% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
EVGN FAQ
What was Evogene’s price range in the past 12 months?
Evogene lowest stock price was $2.72 and its highest was $10.40 in the past 12 months.
What is Evogene’s market cap?
Currently, no data Available
When is Evogene’s upcoming earnings report date?
Evogene’s upcoming earnings report date is Nov 13, 2024 which is in 54 days.
How were Evogene’s earnings last quarter?
Evogene released its earnings results on Aug 22, 2024. The company reported -$1.06 earnings per share for the quarter, beating the consensus estimate of -$1.25 by $0.19.
Is Evogene overvalued?
According to Wall Street analysts Evogene’s price is currently Undervalued.
Does Evogene pay dividends?
Evogene does not currently pay dividends.
What is Evogene’s EPS estimate?
Evogene’s EPS estimate is -$1.01.
How many shares outstanding does Evogene have?
Evogene has 5,058,488 shares outstanding.
What happened to Evogene’s price movement after its last earnings report?
Evogene reported an EPS of -$1.06 in its last earnings report, beating expectations of -$1.25. Following the earnings report the stock price went down -10.804%.
Which hedge fund is a major shareholder of Evogene?
Among the largest hedge funds holding Evogene’s share is ARK Investment Management LLC. It holds Evogene’s shares valued at N/A.
---
Evogene Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$17.25 (551.14% Upside)
$17.25 (551.14% Upside)
Hedge Fund Trend
Decreased
By 361.2K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 1.8%
Last 30 Days ▲ 2.2%
Last 30 Days ▲ 2.2%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-59.22%
12-Months-Change
Fundamentals
Return on Equity
-228.95%
Trailing 12-Months
Asset Growth
-23.19%
Trailing 12-Months
Company Description
Evogene
Evogene Ltd. operates as a plant genomics company. It utilizes a proprietary integrated technology infrastructure to enhance seed traits underlying crop productivity. It also offers a solution for crop productivity improvement through biotechnology and breeding using a technology infrastructure that is based on deep scientific understanding of plant genomics and proprietary computational capabilities. The company was founded by Amir Barzilay and Hagai Karchi in 2002 and is headquartered in Rehovot, Israel.
---
EVGN Stock 12 Month Forecast
Average Price Target
$17.25
▲(551.14% Upside)
Technical Analysis
Best Analysts Covering EVGN
1 Year
1 Year Success Rate
1/14 ratings generated profit
1 Year Average Return
-52.00%
assigned a buy rating 29 days ago
Copying Ben Klieve's trades and holding each position for 1 Year would result in 7.14% of your transactions generating a profit, with an average return of -52.00% per trade.
---